collection
Collections Most Read Papers - Surgery - S...

Most Read Papers - Surgery - Surgical Oncology

Most Read Papers - Surgery - Surgical Oncology

https://read.qxmd.com/read/38583912/simultaneous-resection-for-colorectal-cancer-with-synchronous-liver-metastases-current-state-of-the-art
#1
REVIEW
Nikolaos Machairas, Marcello Di Martino, Florian Primavesi, Patrick Underwood, Martin de Santibanes, Ioannis Ntanasis-Stathopoulos, Iveta Urban, Diamantis I Tsilimigras, Ajith K Siriwardena, Adam E Frampton, Timothy M Pawlik
BACKGROUND: A large proportion of patients with colorectal cancer (CRC) presents with synchronous colorectal liver metastases (sCRLM) at diagnosis. Surgical approaches for patients with sCRLM have evolved over the past decades. Simultaneous resection (SR) of CRC and sCRLM for selected patients has emerged as a safe and efficient alternative approach to traditional staged resections. METHODS: A comprehensive review of the literature was performed using MEDLINE/PubMed and Web of Science databases with the end of search date October 30, 2023...
April 2024: Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38627808/repeat-cytoreductive-surgery-with-hipec-for-colorectal-peritoneal-metastases-a-systematic-review
#2
REVIEW
Mina Sarofim, Ruwanthi Wijayawardana, Nima Ahmadi, David L Morris
BACKGROUND: Colorectal peritoneal metastases (CRPM) are present in 10-20% of patients at the time of their initial cancer diagnosis, and affects over 20% of those who develop colorectal cancer recurrence. Cytoreductive surgery (CRS) with HIPEC is firmly established as the optimal surgical treatment, but there is very little known about the benefit of repeat or iterative CRS. The aim of this review is to provide a systematic evaluation of the perioperative complications, survival outcomes and quality of life in patients undergoing repeat CRS with HIPEC for CRPM...
April 17, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/37718994/kite-mastopexy-small-scar-and-tissue-conserving-technique
#3
JOURNAL ARTICLE
Laura C Cala Uribe, Mauricio Perez Pachon, Andres Villate Hernandez, Andreina Zannin Ferrero
BACKGROUND: Breasts are considered one of the most physically and sexually appealing features of the female body. Reduction/augmentation techniques have greatly evolved in the last decades.We are reporting our experience with an innovative technique for mastopexy that recovers the aesthetics of the breast and avoids over-resection of its lower pole. METHODS: Inclusion criteria were women who underwent kite mastopexy with or without implants between January 2018 and May 2022 in a single center (Bogota, Colombia)...
September 2023: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/38558735/the-role-of-human-epidermal-growth-factor-receptor-2-her2-targeted-therapies-in-early-stage-breast-cancer-current-practices-treatment-de-escalation-and-future-prospects
#4
REVIEW
Mohamed Hashem, Shazza Rehman, Mohamed Salhab
Human epidermal growth factor receptor 2 (HER2)-targeted therapy has transformed the treatment paradigm for early-stage HER2-positive breast cancer, providing personalized and effective interventions. This comprehensive review delves into the current state of HER2-targeted therapies, emphasizing pivotal clinical trials that have demonstrated their substantial impact on long-term outcomes. Combination therapies that integrate HER2-targeted agents with chemotherapy exhibit enhanced tumor responses, particularly in neoadjuvant settings...
February 2024: Curēus
https://read.qxmd.com/read/38636304/adjuvant-chemotherapy-in-stage-1-colon-cancer-patient-characteristics-and-survival-analysis-from-the-national-cancer-database
#5
JOURNAL ARTICLE
Angela Ting-Wei Hsu, Joshua H Wolf, Christopher R D'Adamo, Jessica Felton, Sonal Paul, Pallavi Kumar, Arun A Mavanur
BACKGROUND: A subset of patients in ACS-NCDB with stage-1 colon cancer received adjuvant chemotherapy (AC), in contrast to national guidelines. This study aimed to define this population and evaluate associations between AC and survival. METHODS: Patients with T1-2N0 colon cancer from 2004 to 2016 were separated into AC and non-AC groups. Adverse pathological features (APF) included T2, poor differentiation, lymphovascular invasion, positive margin, and inadequate lymph nodes (<12)...
April 15, 2024: Surgical Oncology
https://read.qxmd.com/read/38541244/current-status-of-anti-reflux-surgery-as-a-treatment-for-gerd
#6
REVIEW
Jooyeon Lee, Inhyeok Lee, Youjin Oh, Jeong Woo Kim, Yeongkeun Kwon, Ahmad Alromi, Mohannad Eledreesi, Alkadam Khalid, Wafa Aljarbou, Sungsoo Park
Anti-reflux surgery (ARS) is an efficient treatment option for gastroesophageal reflux disease (GERD). Despite growing evidence of the efficacy and safety of ARS, medications including proton pump inhibitors (PPIs) remain the most commonly administered treatments for GERD. Meanwhile, ARS can be an effective treatment option for patients who need medications continuously or for those who are refractory to PPI treatment, if proper candidates are selected. However, in practice, ARS is often regarded as a last resort for patients who are unresponsive to PPIs...
March 21, 2024: Medicina
https://read.qxmd.com/read/38595826/von-hipple-lindau-syndrome-with-family-history-a-case-report-and-seventeen-years-follow-up-study
#7
XueMei Fan, Shuai Wang, Tianwen Chen, Wei Hu, Hui Yang
BACKGROUND: Von-Hipple Lindau syndrome is an uncommon autosomal dominant disorder. 17 years ago we diagnosed a young woman with VHL syndrome validated by Sanger sequencing, her family members were genetically tested as well, and 187 healthy people were randomly selected for VHL genetic testing as controls. We analyze the clinical and genetic characteristics of VHL syndrome in a Chinese lineage and with 17-year follow-up. CASE PRESENTATION: A woman was finally diagnosed with VHL syndrome due to the detection of a missense mutation c...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38580855/the-influence-of-a-previous-implant-based-breast-reconstruction-on-postoperative-sensation-of-the-deep-inferior-epigastric-artery-perforator-flap
#8
JOURNAL ARTICLE
Joep A F van Rooij, Ennie Bijkerk, René R J W van der Hulst, Stefania M H Tuinder
BACKGROUND: Implants and DIEP flaps have different outcomes regarding postoperative breast sensation. When compared to the preoperative healthy breast, implant-based breast reconstruction (IBBR) negatively influences postoperative breast sensation. However, it is currently unknown whether a prior IBBR also influences postoperative sensation of a replacing DIEP flap. The goal of this cohort study is to evaluate the influence of an IBBR on the postoperative sensation of a replacing DIEP flap...
April 6, 2024: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://read.qxmd.com/read/38601368/post-operative-surveillance-and-management-of-intrahepatic-cholangiocarcinoma-using-circulating-tumor-dna-a-case-report
#9
Gary Monroe, Midhun Malla
Cholangiocarcinomas (CCAs) are a subclass of biliary tract tumors that arise from the epithelial lining of bile ducts. They are subdivided broadly into intra- and extrahepatic CCA, with extrahepatic being the more common. Circulating tumor DNA (ctDNA) is a form of liquid biopsy obtained from dying tumor cells in the peripheral blood. Assays may be tumor-informed or tumor-agnostic, with the former requiring tissue sampling to evaluate detectable mutations present in an individual patient's tumor. Here we present a case of intrahepatic CCA managed with hepatectomy followed by adjuvant chemotherapy, with subsequent surveillance and management guided by tumor-informed ctDNA...
March 2024: Curēus
https://read.qxmd.com/read/38571688/sentinel-lymph-node-biopsy-after-neoadjuvant-chemotherapy-in-cn0-breast-cancer-impact-of-her2-positive-status-on-survival
#10
JOURNAL ARTICLE
Juan Alors-Ruiz, Salomé Sanz-Viedma, Francisco Javier Fernández-Garcia, Francisco Sendra-Portero
OBJECTIVE: High rates of negative sentinel lymph node biopsy (SLNB) in clinically node-negative (cN0) breast cancer (BC) after neoadjuvant chemotherapy (NAC) have been described. These results are associated with triple-negative (TNBC) and human epidermal growth factor receptor 2 (HER2+) subtypes achieving pathologic complete response (pCR). This study evaluates predictive variables and survival in order to assess the possible omission of SLNB after NAC. MATERIALS AND METHODS: Prospective study of women with cN0 BC treated with NAC and subsequent surgery, between April 2010 and May 2021...
April 2024: European Journal of Breast Health
https://read.qxmd.com/read/38542008/unraveling-the-connection-pancreatic-cancer-cells-and-schwann-cells
#11
JOURNAL ARTICLE
Ingrid Garajová, Francesca Trentini, Francesco Leonardi, Elisa Giovannetti
Pancreatic ductal adenocarcinoma is one of the most lethal solid malignancies, characterized by its aggressiveness and metastatic potential, with a 5-year survival rate of only 13%. Progress in the management of metastatic disease has been modest. A robust connection between nervous system and tumor progression exists, with prominent neural alterations having been observed during pancreatic cancer's progression, including neural hypertrophy, neural density, and neural remodeling. The pancreatic tumor microenvironment includes s set of cells and structures that constantly dialogue with cancer cells, influencing its growth and behavior...
March 20, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38549376/rnai-mediated-silencing-of-stat3-pd-l1-in-tumor-associated-immune-cells-induces-robust-anti-tumor-effects-in-immunotherapy-resistant-tumors
#12
JOURNAL ARTICLE
Shanthi Ganesh, Min Ju Kim, Jenny Lee, Xudong Feng, Krisjanis Ule, Amy Mahan, Harini Sivagurunatha Krishnan, Zhe Wang, Maryam Yahyaee Anzahaee, Garima Singhal, Ilia Korboukh, Jennifer A Lockridge, Laura Sanftner, Rene Rijnbrand, Marc Abrams, Bob D Brown
Malignant tumors are often associated with an immunosuppressive tumor microenvironment (TME), rendering most of them resistant to standard-of-care immune checkpoint inhibitors (CPIs). Signal transducer and activator of transcription 3 (STAT3), a ubiquitously expressed transcription factor, has well-defined immunosuppressive functions in several leukocyte populations within the TME. Since the STAT3 protein has been challenging to target using conventional pharmaceutical modalities, we investigated the feasibility of applying systemically delivered RNA interference (RNAi) agents to silence its mRNA directly in tumor-associated immune cells...
March 27, 2024: Molecular Therapy
https://read.qxmd.com/read/38530108/lifecycle-of-surgical-devices-global-environmental-and-regulatory-considerations
#13
JOURNAL ARTICLE
Eric R Wahlstedt, John C Wahlstedt, Jenna S Rosenberg, Catherine R deVries
BACKGROUND: Technological advancements, improved surgical access, and heightened demand for surgery have fueled unprecedented device and supply turnover impelling wealthy hospitals to upgrade continually and sell, donate, recycle, or dispose of used, expired, antiquated, or surplus goods. This paper reviews the issues related to device and supply lifecycles and discusses the opportunities and challenges they present for sustainable surgical growth in low- and middle-income (LMICs) countries...
March 26, 2024: World Journal of Surgery
https://read.qxmd.com/read/38531729/debulking-hepatectomy-for-colorectal-liver-metastasis-analysis-of-risk-factors-for-progression-free-survival
#14
JOURNAL ARTICLE
Alessandro D Mazzotta, Nita Usdin, Diab Samer, Ecoline Tribillon, Brice Gayet, David Fuks, Christophe Louvet, Olivier Soubrane
BACKGROUND: The study explores the role of liver debulking surgery in cases of unresectable colorectal liver metastases (CRLM), challenging the traditional notion that surgery is not a valid option in such scenarios. MATERIALS AND METHODS: Patients with advanced but resectable disease who underwent surgery with a curative intent (Group I) and those with advanced incompletely resectable disease who underwent a "debulking" hepatectomy (Group II) were compared. RESULTS: There was no difference in the intra-operative and post-operative results between the two groups...
March 12, 2024: Surgical Oncology
https://read.qxmd.com/read/38484493/evaluation-of-traditional-targeted-axillary-dissection-eligibility-criteria-for-node-positive-breast-cancer-after-neoadjuvant-chemotherapy-in-a-prospective-multicenter-registry
#15
MULTICENTER STUDY
Catherine Loveland-Jones, John Gaughan, Abigail Caudle, Brittany Murphy, Laila Samiian, Stephanie Byrum, Kristen Brill, Pauline Germaine, Xinmin Zhang, Kay Yoon-Flannery, Teralyn Carter, Adrian Lopez, Ryan Gruner, Michele Fantazzio, Henry Kuerer
INTRODUCTION: Targeted axillary dissection (TAD) is performed after neoadjuvant systemic therapy (NST) to decrease the rate of non-therapeutic axillary dissection (ALND) for patients with node-positive breast cancer. In order to ensure the oncologic safety of TAD, eligibility criteria resulting in a low false negative rate (FNR) have been proposed. The purpose of this study was to evaluate the utility of the traditional criteria. METHODS: Data was collected from a prospective multicenter registry...
April 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38503223/staging-laparoscopy-with-peritoneal-lavage-to-identify-peritoneal-metastases-and-free-intraperitoneal-cancer-cells-in-the-management-of-locally-advanced-gastric-cancer
#16
JOURNAL ARTICLE
B Huang, V Rampulla, M Ri, M Lindblad, M Nilsson, I Rouvelas, F Klevebro
INTRODUCTION: Gastric cancer often presents in advanced stage with a significant risk for peritoneal dissemination. Staging laparoscopy can be used to detect peritoneal carcinomatosis (PC+) and free cancer cells in peritoneal lavage cytology (CY+). The current study aimed to present the outcomes of staging laparoscopy and the prognosis of PC+ and CY+ in a Swedish high-volume center. MATERIALS AND METHODS: A cohort study including all consecutive patients with locally advanced gastric cancer who underwent staging laparoscopy between February 2008 and October 2022...
March 13, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38230766/cancer-statistics-2024
#17
JOURNAL ARTICLE
Rebecca L Siegel, Angela N Giaquinto, Ahmedin Jemal
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2020) and mortality data collected by the National Center for Health Statistics (through 2021). In 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both the adjuvant and metastatic settings...
January 17, 2024: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/38453307/damage-control-laparotomy-and-management-of-the-open-abdomen
#18
REVIEW
Jennifer Serfin, Christopher Dai, James Reece Harris, Nathan Smith
Management of the open abdomen has been used for decades by general surgeons. Techniques have evolved over those decades to improve control of infection, fluid loss, and improve the ability to close the abdomen to avoid hernia formation. The authors explore the history, indications, and techniques of open abdomen management in multiple settings. The most important considerations in open abdomen management include the reason for leaving the abdomen open, prevention and mitigation of ongoing organ dysfunction, and eventual plans for abdominal closure...
April 2024: Surgical Clinics of North America
https://read.qxmd.com/read/38500769/the-therapeutic-potential-of-natural-metabolites-in-targeting-endocrine-independent-her-2-negative-breast-cancer
#19
REVIEW
Mirosława Püsküllüoğlu, Izabela Michalak
Breast cancer (BC) is a heterogenous disease, with prognosis and treatment options depending on Estrogen, Progesterone receptor, and Human Epidermal Growth Factor Receptor-2 (HER-2) status. HER-2 negative, endocrine-independent BC presents a significant clinical challenge with limited treatment options. To date, promising strategies like immune checkpoint inhibitors have not yielded breakthroughs in patient prognosis. Despite being considered archaic, agents derived from natural sources, mainly plants, remain backbone of current treatment...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38517596/treatment-options-for-distal-rectal-cancer-in-the-era-of-organ-preservation
#20
REVIEW
Chen Wang, Xiaoliang Liu, Weiping Wang, Zheng Miao, Xiaoyan Li, Dingchao Liu, Ke Hu
The introduction of total mesorectal excision into the radical surgery of rectal cancer has significantly improved the oncological outcome with longer survival and lower local recurrence. Traditional treatment modalities of distal rectal cancer, relying on radical surgery, while effective, take their own set of risks, including surgical complications, potential damage to the anus, and surrounding structure owing to the pursuit of thorough resection. The progress of operating methods as well as the integration of systemic therapies and radiotherapy into the peri-operative period, particularly the exciting clinical complete response of patients after neoadjuvant treatment, have paved the way for organ preservation strategy...
March 22, 2024: Current Treatment Options in Oncology
label_collection
label_collection
1073
1
2
2024-04-02 00:25:19
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.